Top Industry News

Baxter, a medical technology and healthcare company, has provided an update on its North Cove, North Carolina, injectables manufacturing facility, which was flooded and impacted by the rain and storm…

The latest from CDMOs, CMOs, and suppliers featuring Samsung Biologics, Rentschler Biopharma, Avantor, Mikart, Northway Biotech, Nucleus RadioPharma, NorthStar Medical, Flamma, Bormioli Pharma, and Southwest Research Institute.   Chemicals/Chemical API Manufacturing *…

A roundup of news from Camurus, Merck & Co./Modifi Biosciences and Telix. Highlights below.   Mfg News * Camurus Receives FDA Complete Response Letter for Contract Mfg Issue M&A News * Merck Acquires Modifi…

A roundup of bio/pharmaceutical partnering news from GSK/Cambridge University and Bristol Myers Squibb/Evotec.  * GSK, Cambridge University In $65-M Immune Disease Research Pact  * Evotec, BMS Expand Molecular Glue Degrader…

Catalent has agreed to sell its oral solids development and small-scale manufacturing facility in Somerset, New Jersey, to Ardena, a Ghent, Belgium-based CDMO of drug substances and drug products.   The…

Lundbeck, a Copenhagen, Denmark-based bio/pharmaceutical company, has agreed to acquire Longboard Pharmaceuticals, a La Jolla, California-based clinical-stage bio/pharmaceutical company developing medicines for neurological diseases, for $2.6 billion.   Longboard’s lead asset…

A roundup of manufacturing news from Lilly, Chiesi, CSL, GSK, Sanofi, Ferring Pharmaceuticals, and Zealand Pharma. Highlights below.  * Chiesi Launches New $434-M Biotech Center of Excellence  * US Gov’t Awards $72-M…

The latest news on mergers and acquisitions featuring Merck & Co./Curon Biopharmaceutical and Sanofi/Recordati. Highlights below.  * Merck Completes $700-M Acquisition of Curon’s Bispecific Antibody * Recordati To Acquire Rare-Disease Drug…

A roundup of bio/pharmaceutical partnering news from Astellas/AviadaBio, Merck & Co./Mestag, Sanofi/Orano Med, Teva/mAbxience and Viatris/Lexicon Pharmaceuticals.  * Astellas, AviadaBio In $2.23-Bn Gene-Therapy Pact * Merck & Co., Mestag In $1.9-Bn…

GSK has reached a $2.2-billion settlement agreement with regard to pending product liability litigation in US state courts over Zantac (ranitidine), an antacid.   The litigation stemmed from plaintiffs’ claims that…